K. D. Horvei

Murine and Human Lupus Nephritis: Pathogenic Mechanisms and Theoretical Strategies for Therapy.

O. Rekvig, H. Pedersen, K. D. Horvei, 2015, Seminars in nephrology.

Lupus nephritis: low urinary DNase I levels reflect loss of renal DNase I and may be utilized as a biomarker of disease progression

H. Holdaas, P. Meroni, O. Rekvig, 2018, The journal of pathology. Clinical research.

Lupus nephritis progression in FcγRIIB-/-yaa mice is associated with early development of glomerular electron dense deposits and loss of renal DNase I in severe disease

T. Winkler, O. Rekvig, S. Fismen, 2017, PloS one.

An observational study to identify the prevalence of thrombocytopenia and anti‐PF4/polyanion antibodies in Norwegian health care workers after COVID‐19 vaccination

Anna Eriksson, W. Ghanima, H. Jacobsen, 2021, Journal of Thrombosis and Haemostasis.

IL-1β Promotes a New Function of DNase I as a Transcription Factor for the Fas Receptor Gene

O. Rekvig, T. Nijenhuis, J. van der Vlag, 2018, Front. Cell Dev. Biol..

Future Perspectives on Pathogenesis of Lupus Nephritis: Facts, Problems, and Potential Causal Therapy Modalities.

O. Rekvig, H. Pedersen, K. D. Horvei, 2016, The American journal of pathology.

SARS-CoV-2 vaccines are not associated with hypercoagulability in apparently healthy people

P. Sandset, L. Garabet, A. Eriksson, 2022, Research and Practice in Thrombosis and Haemostasis.

Kidney tertiary lymphoid structures in Lupus Nephritis develop into large interconnected networks and resemble lymph nodes in gene signature.

C. Fenton, H. Pedersen, K. D. Horvei, 2020, The American journal of pathology.

Future Perspectives on Pathogenesis of Lupus Nephritis: Facts, Problems, and Potential Causal Therapy Modalities.

O. Rekvig, H. Pedersen, K. D. Horvei, 2016, The American journal of pathology.